Form 4: Lam Research CEO Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Lam Research President and CEO Timothy Archer executed a planned sale of company stock following the exercise of employee stock options.

Summary

  • Timothy Archer, President and CEO of Lam Research Corp (LRCX), reported transactions involving company common stock.
  • On December 17, 2025, Archer exercised employee stock options to acquire 113,300 shares of common stock at an exercise price of $17.675 per share.
  • Concurrently, Archer sold 113,300 shares of common stock at a price of $163.86 per share.
  • Additionally, Archer sold an unrelated 50,000 shares of common stock at a price of $163.86 per share.
  • All reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Archer on August 19, 2025.
  • Following these transactions, Archer directly beneficially owns 932,409 shares of common stock, which includes shares subject to unvested restricted stock units.
  • Archer also indirectly beneficially owns 48,025.816 shares through a 401(k) and 5,670.097 shares through a spouse's 401(k).

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider transaction (option exercise and subsequent sale), which is a routine disclosure and does not inherently indicate positive or negative sentiment about the company's future performance. The transactions were executed under a Rule 10b5-1 plan, suggesting a non-discretionary sale.

Positives

  • The exercise of stock options indicates a significant personal gain for the executive, reflecting the company's stock appreciation since the options were granted.
  • The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a structured approach to insider trading and helps mitigate concerns about opportunistic selling.

Negatives

  • The sale of a substantial number of shares by a key executive, even if pre-planned, could be perceived by some investors as a lack of confidence, although this is often a routine part of executive compensation and diversification.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction for an executive at a major semiconductor equipment company. Such transactions are common in the industry as part of executive compensation and personal financial planning, especially when executed under a Rule 10b5-1 plan.

Stakeholder Impact

  • Shareholders: The sale of shares by the CEO, even if planned, might lead to minor scrutiny, but the pre-arranged nature typically mitigates significant concern. The remaining substantial direct and indirect holdings indicate continued alignment with shareholder interests.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
03/01/2020First installment date for employee stock options to become exercisable.
03/01/2021Second installment date for employee stock options to become exercisable.
03/01/2022Third installment date for employee stock options to become exercisable.
08/19/2025Date the Rule 10b5-1 trading plan was adopted by Timothy Archer.
12/17/2025Date of reported stock option exercise and common stock sales.
12/18/2025Date the Form 4 was signed by Marta Woods by Power of Attorney.
03/01/2026Expiration date for the employee stock options.

Recommendation

hold

The Form 4 details a pre-planned insider transaction involving the exercise of stock options and subsequent sale of shares by the CEO. This is a routine disclosure and does not provide new fundamental information about the company's operational performance or future prospects to warrant a change in investment recommendation. Investors should consider broader company financials and market conditions.

Keywords

Lam Research, LRCX, Timothy Archer, Insider Trading, Stock Options, Form 4, SEC Filing, Executive Compensation, Stock Sale, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.